ArticleAntimicrobial agents and chemotherapy2021

Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections.

Adam J Plaunt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.